Cargando…
58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194802/ http://dx.doi.org/10.1097/01.GOX.0000937824.10049.d5 |
_version_ | 1785044091920187392 |
---|---|
author | Topley, Max Crotty, Anne-Marie Kawaja, Michael Michael Hendry, J. |
author_facet | Topley, Max Crotty, Anne-Marie Kawaja, Michael Michael Hendry, J. |
author_sort | Topley, Max |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10194802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101948022023-05-19 58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model Topley, Max Crotty, Anne-Marie Kawaja, Michael Michael Hendry, J. Plast Reconstr Surg Glob Open PSRC 2023 Meeting Abstract Supplement Lippincott Williams & Wilkins 2023-05-19 /pmc/articles/PMC10194802/ http://dx.doi.org/10.1097/01.GOX.0000937824.10049.d5 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | PSRC 2023 Meeting Abstract Supplement Topley, Max Crotty, Anne-Marie Kawaja, Michael Michael Hendry, J. 58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model |
title | 58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model |
title_full | 58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model |
title_fullStr | 58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model |
title_full_unstemmed | 58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model |
title_short | 58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model |
title_sort | 58. the epidermal growth factor receptor (egfr) inhibitor gefitinib enhances in vitro and in vivo peripheral nerve regeneration in a mouse median nerve injury model |
topic | PSRC 2023 Meeting Abstract Supplement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194802/ http://dx.doi.org/10.1097/01.GOX.0000937824.10049.d5 |
work_keys_str_mv | AT topleymax 58theepidermalgrowthfactorreceptoregfrinhibitorgefitinibenhancesinvitroandinvivoperipheralnerveregenerationinamousemediannerveinjurymodel AT crottyannemarie 58theepidermalgrowthfactorreceptoregfrinhibitorgefitinibenhancesinvitroandinvivoperipheralnerveregenerationinamousemediannerveinjurymodel AT kawajamichael 58theepidermalgrowthfactorreceptoregfrinhibitorgefitinibenhancesinvitroandinvivoperipheralnerveregenerationinamousemediannerveinjurymodel AT michaelhendryj 58theepidermalgrowthfactorreceptoregfrinhibitorgefitinibenhancesinvitroandinvivoperipheralnerveregenerationinamousemediannerveinjurymodel |